XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 41,381 $ 33,159 $ 16,090
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 19,799 20,520 19,389
Provision for credit losses 2,818 1,783 2,318
Stock-based compensation expense 5,959 5,513 3,370
Deferred income tax expense (benefit) 3,036 (692) 4,597
Amortization of Intangible Assets 1,286 1,285 1,299
Amortization of debt issuance costs 552 576 782
Amortization and accretion of debt 493 439 523
Loss on extinguishment of debt 190 23,807 6
Net loss on divestitures, disposals and impairment charges 2,029 847 21,693
Gain on insurance reimbursements (3,471) 0 (97)
Other (155) 0 19
Changes in operating assets and liabilities that provided (used) cash:      
Accounts and preneed receivables (5,358) (4,090) (4,279)
Inventories, prepaid and other current assets 2,295 (4,449) 3,516
Intangible and other non-current assets (1,917) (1,181) (1,015)
Preneed funeral and cemetery trust investments (17,679) (31,349) (5,043)
Accounts payable (101) 522 2,702
Accrued and other liabilities (9,120) 3,485 10,784
Deferred preneed funeral and cemetery revenue 1,302 5,010 528
Deferred preneed funeral and cemetery receipts held in trust 17,685 29,061 5,733
Net cash provided by operating activities 61,024 84,246 82,915
Cash flows from investing activities:      
Acquisitions of businesses and real estate (33,876) (3,285) (28,011)
Proceeds from divestitures and sale of other assets 5,027 7,875 8,541
Proceeds from insurance reimbursements 2,440 7,758 248
Capital expenditures (26,081) (24,883) (15,198)
Net cash used in investing activities (52,490) (12,535) (34,420)
Cash flows from financing activities:      
Borrowings from the credit facility 155,400 266,168 109,500
Payments against the credit facility (120,100) (157,968) (146,100)
Payment to redeem the 6.625% senior notes due 2026 0 (400,000) 0
Payment of call premium for the redemption of the 6.625% senior notes due 2026 0 (19,876) 0
Proceeds from the issuance of the 4.25% senior notes due 2029 0 395,500 0
Payment of debt issuance costs for the credit facility and 4.25% senior notes due 2029 (922) (2,197) (78)
Conversions and maturity of the convertible notes 0 (3,980) (4,563)
Payments on acquisition debt and obligations under finance leases (882) (1,331) (1,745)
Payments on contingent consideration recorded at acquisition date 0 (461) (169)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 1,745 2,644 1,229
Taxes paid on restricted stock vestings and exercise of stock options (327) (2,647) (348)
Dividends paid on common stock (6,763) (7,264) (6,048)
Purchase of treasury stock (36,663) (140,040) 0
Net cash used in financing activities (8,512) (71,452) (48,322)
Net increase in cash and cash equivalents 22 259 173
Cash and cash equivalents at beginning of year 1,148 889 716
Cash and cash equivalents at end of year $ 1,170 $ 1,148 $ 889